Expert Review of Vaccines

Aims & Scope

Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines.

Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism.

All articles are subject to rigorous peer-review.

The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines.

Expert Review of Vaccines facilitates decision making to drive forward this exciting field.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Pharmacology, Toxicology and Pharmaceutics, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 6,075.00 AUD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Virus-like particles in vaccine development

  Citation: 714

  Authors: António, Maria Candida M, Leda R, Manuel JT, Paula M

• Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications

  Citation: 711

  Authors: Eve, Maryline, Noni E

• CpG DNA as a vaccine adjuvant

  Citation: 697

  Authors: Christian, Gan, Folkert, Takeshi, Dennis M

• Vaccines for fish in aquaculture

  Citation: 582

  Authors: Ingunn, Bjørn, Eirik, Petter

• The fundamental link between pneumococcal carriage and disease

  Citation: 565

  Authors: Birgit, Kari, Helena, David, Ron, Katherine L

• Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses

  Citation: 464

  Authors: Moses O, Amit, Zhengrong

• Poultry coccidiosis: recent advancements in control measures and vaccine development

  Citation: 459

  Authors: Rami A, Hyun S

• Adjuvant system AS01: helping to overcome the challenges of modern vaccines

  Citation: 437

  Authors: Arnaud M., Béatrice, Alberta, Nadia, Catherine, Nathalie

• GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives

  Citation: 402

  Authors: Nathalie, Patrick, Marcelle

• Development and evaluation of AS03, an Adjuvant System containing α-tocopherol and squalene in an oil-in-water emulsion

  Citation: 309

  Authors: Nathalie, David W, Arnaud M